Working Paper 132 “All offices” experience of term assurances, 2015-2018 (Issue date: 07/05/2020)
Working Paper 125 Additional analysis of the experience of term assurances, 2011-2016 (Issue date: 15/11/2019)
Working Paper 123

"All offices” experience of term assurances, 2011-2016 (v01: issue date: 18/07/2019; v02 issue date: 07/05/2020)

Working Paper 110 Working Paper 110: Using the CMI Mortality Projections Model for assured lives (Issue date: 04/10/2018; Response date: 31/12/2018)
Working Paper 108 Interim “all offices” experience of term assurances, 2011-2015 (v01 issue date: 08/06/2018; v02 issue date: 07/05/2020; Response date: 12/07/2018)
Working Paper 94 Final "08" Series accelerated critical illness and term mortality tables (Issue date: 27/01/2017)
Working Paper 92 Proposed "08" Series term mortality tables (Issue Date: 07/10/2016; Response date: 30/11/2016)

Working Paper 89

Proposed "08" Series accelerated critical illness tables (Issue date: 06/05/2016; Reissued: 07/10/2016; Response date: 30/11/2016)

Working Paper 75 

All-Offices Mortality and Critical Illness Experience for the 2007-2010 Quadrennium (Issue date:  03/12/2014; Reissued: 01/02/2016)

Working Paper 67

A revised approach for analysing CMI critical illness experience and restated results for accelerated business, 2003-2006 (Issue date: 10/05/2013)

Working Paper 58

Supplementary analyses to CMI critical illness diagnosis rates for accelerated business, 2003-2006

Working Paper 52

Cause-specific CMI critical illness diagnosis rates for accelerated business, 2003-2006 (Issue date: 15/06/2011)

Working Paper 50

CMI critical illness diagnosis rates for accelerated business 2003-2006 (Issue date: 24/01/2011)

Working Paper 43

CMI critical illness diagnosis rates for accelerated business 1999-2004 (Issue date: 12/02/2010)

Working Paper 36

The mortality of impaired assured lives: Report on 1995-2006 experience and consultation on the future of the investigation (Issue date: 14/01/2009)

Working Paper 33

A new methodology for analysing CMI critical illness experience (Issue date: 23/07/2008)

Working Paper 28

Progress towards an improved methodology for analysing CMI critical illness experience (Issue date: 27/07/2007)

Working Paper 18

1999-2002 critical illness experience: feedback on Working paper 14 and future work (Issue date: 01/12/2005)

Working Paper 14

Methodology underlying the 1999-2002 CMI critical illness experience investigation (Issue date: 05/05/2005)

Working Paper 12

The graduation of the CMI 1999-2002 mortality experience: feedback on Working paper 8 and proposed assured lives graduations (Issue date: 11/04/2005)

 

Contact Details

If you have any questions about the CMI please email

info@cmilimited.co.uk

Filter or search events

Start date
E.g., 04/03/2021
End date
E.g., 04/03/2021

Events calendar

  • Finance in the Public Interest Series

    16 March 2021 - 23 March 2021

    Spaces available

    There is widening debate that many of our social, financial and regulatory institutions need to be rethought so that we can create more sustainable futures, particularly in light of the Covid-19 pandemic, the policy/macro-economic response to the pandemic and how it affects consumers, as well as the impending climate crisis. This multi-day series of three keynote webinars, individually presented by leading economist John Kay, Sir Paul Collier, Professor of Economics and Public Policy at the Blavatnik School of Government, Ashok Gupta, Chair at Mercer Ltd, and Nico Aspinall, Chief Investment Officer at B&CE, will open up discussion on these essential topics. The series will culminate in a panel session with Chief Economist of the Bank of England, Andy Haldane.

  • The price is righter

    16 March 2021

    Spaces available

    This webinar provides an overview of the state of the UK protection market, and how different insurers are using different levels of sophistication to price (such as using customer demand models). It considers how insurers have implemented these sophisticated pricing techniques, and the practical challenges they have faced.

  • Spaces available

    This discussion will revolve around the latest industry developments including and introduction to Part VII transfers and Schemes of Arrangement (process, parties involved and recent events), insights and lessons from recent with-profits transactions and restructurings (including Equitable Life and Pru-Rothesay), how firms can apply these learnings to future arrangements, and the outlook for future with-profits transactions and restructurings (including the impacts of Covid-19 and Brexit)

     

  • Spaces available

    What is stewardship and how has the landscape changed under the 2020 UK Stewardship Code? How does effective stewardship create long term value for beneficiaries and what roles do asset owners and asset managers play in active stewardship. This webinar will offer answers to these questions in a practical approach to stewardship reporting.

  • Spaces available

    Mis-estimation risk is a key element of demographic risk, and past work has focused on mis-estimation risk on a run-off basis.  However, this does not meet the requirements of regulatory regimes like Solvency II, which demands that capital requirements are set through the prism of a finite horizon like one year.  This paper presents a value-at-risk approach to mis-estimation risk suitable for Solvency II work.